BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36382478)

  • 1. Incidence and morphology of secondary TDP-43 proteinopathies: Part 1.
    Acewicz A; Stępień T; Felczak P; Tarka S; Wierzba-Bobrowicz T
    Folia Neuropathol; 2022; 60(3):267-276. PubMed ID: 36382478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and morphology of secondary TDP-43 proteinopathies: Part 2.
    Acewicz A; Stępień T; Felczak P; Tarka S; Wierzba-Bobrowicz T
    Folia Neuropathol; 2023; 61(2):111-120. PubMed ID: 37587885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
    Mesulam MM; Coventry CA; Bigio EH; Sridhar J; Gill N; Fought AJ; Zhang H; Thompson CK; Geula C; Gefen T; Flanagan M; Mao Q; Weintraub S; Rogalski EJ
    Brain; 2022 Jun; 145(6):2133-2148. PubMed ID: 35441216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 in aging and Alzheimer's disease - a review.
    Wilson AC; Dugger BN; Dickson DW; Wang DS
    Int J Clin Exp Pathol; 2011 Jan; 4(2):147-55. PubMed ID: 21326809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy.
    Yokota O; Davidson Y; Bigio EH; Ishizu H; Terada S; Arai T; Hasegawa M; Akiyama H; Sikkink S; Pickering-Brown S; Mann DM
    Acta Neuropathol; 2010 Jul; 120(1):55-66. PubMed ID: 20512649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
    Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new dementia group caused by TDP-43 abnormality].
    Arai T; Hosokawa M; Hasegawa M; Akiyama H; Asada T
    Seishin Shinkeigaku Zasshi; 2011; 113(6):574-83. PubMed ID: 21815469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use.
    López-Carbonero JI; García-Toledo I; Fernández-Hernández L; Bascuñana P; Gil-Moreno MJ; Matías-Guiu JA; Corrochano S
    Transl Neurodegener; 2024 Jun; 13(1):29. PubMed ID: 38831349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.
    Rusina R; Kovacs GG; Fiala J; Hort J; Ridzoň P; Holmerová I; Ströbel T; Matěj R
    BMC Neurol; 2011 May; 11():50. PubMed ID: 21569259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
    James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
    Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies.
    Maldonado-Díaz C; Hiya S; Yokoda RT; Farrell K; Marx GA; Kauffman J; Daoud EV; Gonzales MM; Parker AS; Canbeldek L; Kulumani Mahadevan LS; Crary JF; White CL; Walker JM; Richardson TE
    Acta Neuropathol; 2024 Mar; 147(1):58. PubMed ID: 38520489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autopsy case of corticobasal syndrome due to asymmetric degeneration of the motor cortex and substantia nigra with TDP-43 proteinopathy, associated with Alzheimer's disease pathology.
    Tando S; Kasai T; Mizuta I; Takahashi H; Yaoi T; Saito K; Hojo T; Mizuno T; Hasegawa M; Itoh K
    Neuropathology; 2021 Jun; 41(3):214-225. PubMed ID: 33537992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice.
    Medina DX; Orr ME; Oddo S
    Neurobiol Aging; 2014 Jan; 35(1):79-87. PubMed ID: 23954172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 Proteinopathy Specific Biomarker Development.
    Cordts I; Wachinger A; Scialo C; Lingor P; Polymenidou M; Buratti E; Feneberg E
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy.
    Koga S; Sanchez-Contreras M; Josephs KA; Uitti RJ; Graff-Radford N; van Gerpen JA; Cheshire WP; Wszolek ZK; Rademakers R; Dickson DW
    Mov Disord; 2017 Feb; 32(2):246-255. PubMed ID: 28009087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
    Kwong LK; Uryu K; Trojanowski JQ; Lee VM
    Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases.
    Warraich ST; Yang S; Nicholson GA; Blair IP
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1606-9. PubMed ID: 20601083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.